Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

Subjects:

Table 1_Centella asiatica enhances diabetic wound healing by decreasing macrophage-driven inflammation via the AKT/MAPK/NF-κB pathway.xlsx by Fugang Xiao (22152127)

Results of Multiple Linear Regression. by Benjamin S. Killen (22766029)

Subjects:

Spatiotemporal Gait Parameters Across Terrains. by Benjamin S. Killen (22766029)

Subjects:

Participant Demographic Information. by Benjamin S. Killen (22766029)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. by Lei Li (29537)

“…<p>(A) NEAT1 expression following siRNA transfection in BEAS-2B cells; (B-D) The expression of NEAT1, miR-204-5p, and Six1 after decreasing NEAT1 expression. * p <0.05, *** p < 0.001, and **** p <0.0001.…”

Diagram of Outdoor Terrains; Participants performed two loops (clockwise and counterclockwise). by Benjamin S. Killen (22766029)

Subjects:

A path model of six-factor self-compassion. by Eriko Takahashi (22608061)

Largest changes in influenza vaccine rates, Pre- vs. Post-COVID-19. by Tyler B. Nofzinger (21560244)

Subjects:

Table 2_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx by Bo Chen (32294)

“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10⁺ CD8⁺ T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”

Image 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.pdf by Bo Chen (32294)

“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10⁺ CD8⁺ T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”

Table 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx by Bo Chen (32294)

“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10⁺ CD8⁺ T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”

Data Sheet 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.zip by Bo Chen (32294)

“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10⁺ CD8⁺ T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”

Changes in HSA outcomes between baseline and six months (N = 60). by Janelli Vallin (14540858)

Subjects:

Video 2_Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC.mp4 by Lina Ouologuem (22489549)

Video 5_Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC.mp4 by Lina Ouologuem (22489549)

Video 1_Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC.mp4 by Lina Ouologuem (22489549)

Video 6_Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC.mp4 by Lina Ouologuem (22489549)

Data Sheet 2_Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC.docx by Lina Ouologuem (22489549)